Efficacy {FEV1, COPD Exacerbations & HRQoL} & Safety of 5mcg Tiotropium Respimat in COPD
Efficacy {FEV1, COPD Exacerbations & HRQoL} & Safety of 5mcg Tiotropium Respimat in COPD
The objective of the study is to evaluate the long-term (one year) efficacy and safety of tiotropium delivered by the Respimat inhaler in patients with COPD. Specifically, the study will examine the effect of treatment on COPD exacerbations.
Inclusion Criteria:
Exclusion Criteria:
Elizabeth City, North Carolina, United States
Swathmore, Pennsylvania, United States
São Paulo - SP, Brazil
São Paulo - SP, Brazil
Six Four Les Plages, France
Heraklion-Crete, Greece
Andhra Pradesh, India
Andhra Pradesh, India
Gujarat, India
Maharashtra, India
Punjab, India
Tamil Nadu, India
Uttar Pradesh, India
Kelantan Darul Naim, Malaysia
Col. Seccion XVI, Mexico
Guadalajara Jal., Mexico
Hermosillo, Sonora, Mexico
Huixquilucan Edo.Mex., Mexico
Merida Yuc., Mexico
Mexicali Baja California Norte, Mexico
Mérida Yucatán, Mexico
Monterrey, Nuevo León, Mexico
Monterrey, Nuevo León, Mexico
Zapopan, Jal., Mexico
Daejoen, South Korea
Jeonbuk, South Korea
Aston Clinton, Aylesbury, United Kingdom
Saint Just, Penzance, United Kingdom
Sneinton, Nottingham, United Kingdom